← All trials
NCT04473859
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 6, 2008
- Primary completion
- Apr 28, 2009
- Completion date
- Apr 28, 2009
- First posted
- Jul 16, 2020
- Last posted
- Jul 20, 2020
- Enrollment
- 49
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- FirstString Research, Inc.Lead sponsor
- FirstString Research, Inc.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.